Evolution of the Family Equidae, Subfamily Equinae, in North, Central and South America, Eurasia and Africa during the Plio-Pleistocene

Studies of horse evolution arose during the middle of the 19th century, and several hypotheses have been proposed for their taxonomy, paleobiogeography, paleoecology and evolution. The present contribution represents a collaboration of 19 multinational experts with the goal of providing an updated summary of Pliocene and Pleistocene North, Central and South American, Eurasian and African horses. At the present time, we recognize 114 valid species across these continents, plus 4 North African species in need of further investigation. Our biochronology and biogeography sections integrate Equinae taxonomic records with their chronologic and geographic ranges recognizing regional biochronologic frameworks. The paleoecology section provides insights into paleobotany and diet utilizing both the mesowear and light microscopic methods, along with calculation of body masses. We provide a temporal sequence of maps that render paleoclimatic conditions across these continents integrated with Equinae occurrences. These records reveal a succession of extinctions of primitive lineages and the rise and diversification of more modern taxa. Two recent morphological-based cladistic analyses are presented here as competing hypotheses, with reference to molecular-based phylogenies. Our contribution represents a state-of-the art understanding of Plio-Pleistocene Equus evolution, their biochronologic and biogeographic background and paleoecological and paleoclimatic contexts

Evolution of the Family Equidae, Subfamily Equinae, in North, Central and South America, Eurasia and Africa during the Plio-Pleistocene

Studies of horse evolution arose during the middle of the 19th century, and several hypotheses have been proposed for their taxonomy, paleobiogeography, paleoecology and evolution. The present contribution represents a collaboration of 19 multinational experts with the goal of providing an updated summary of Pliocene and Pleistocene North, Central and South American, Eurasian and African horses. At the present time, we recognize 114 valid species across these continents, plus 4 North African species in need of further investigation. Our biochronology and biogeography sections integrate Equinae taxonomic records with their chronologic and geographic ranges recognizing regional biochronologic frameworks. The paleoecology section provides insights into paleobotany and diet utilizing both the mesowear and light microscopic methods, along with calculation of body masses. We provide a temporal sequence of maps that render paleoclimatic conditions across these continents integrated with Equinae occurrences. These records reveal a succession of extinctions of primitive lineages and the rise and diversification of more modern taxa. Two recent morphological-based cladistic analyses are presented here as competing hypotheses, with reference to molecular-based phylogenies. Our contribution represents a state-of-the art understanding of Plio-Pleistocene Equus evolution, their biochronologic and biogeographic background and paleoecological and paleoclimatic contexts. © 2022 by the authors.Open access journalThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at [email protected]

Evolution of the Family Equidae, Subfamily Equinae, in North, Central and South America, Eurasia and Africa during the Plio-Pleistocene

Studies of horse evolution arose during the middle of the 19th century, and several hypotheses have been proposed for their taxonomy, paleobiogeography, paleoecology and evolution. The present contribution represents a collaboration of 19 multinational experts with the goal of providing an updated summary of Pliocene and Pleistocene North, Central and South American, Eurasian and African horses. At the present time, we recognize 114 valid species across these continents, plus 4 North African species in need of further investigation. Our biochronology and biogeography sections integrate Equinae taxonomic records with their chronologic and geographic ranges recognizing regional biochronologic frameworks. The paleoecology section provides insights into paleobotany and diet utilizing both the mesowear and light microscopic methods, along with calculation of body masses. We provide a temporal sequence of maps that render paleoclimatic conditions across these continents integrated with Equinae occurrences. These records reveal a succession of extinctions of primitive lineages and the rise and diversification of more modern taxa. Two recent morphological-based cladistic analyses are presented here as competing hypotheses, with reference to molecular-based phylogenies. Our contribution represents a state-of-the art understanding of Plio-Pleistocene Equus evolution, their biochronologic and biogeographic background and paleoecological and paleoclimatic contexts

italian national survey on molecular epidemiology of pseudomonas aeruginosa from pulmonary infection of cystic fibrosis patients

Pulmonary infection sustained by Pseudomonas aeruginosa is the leading cause of morbidity and mortality of patients affected by Cystic Fibrosis (FC), the most common inherited disease among Caucasian. P. aeruginosa is a ubiquitous microorganism, widely diffuse in the natural and nosocomial environment; however the initial source of acquisition and the way of transmission of this pathogen among CF patients are not yet elucidated. The acquisition of P. aeruginosa by the environment and/or patients to patients transmission was speculated. Moreover in some countries (Australia, United Kingdom) some highly virulent and transmissible strains, called epidemic strains, have spread within the CF care Centres. Aim of the present study was to determine the presence of possible diffuse lineages and the cross-infection degree of P. aeruginosa among Italian CF patients. For this purpose we carried out a national survey, determining the genetic relationship, by molecular typing of a collection of 530 strains recovered from respiratory specimens of 335 patients colonised in follow-up at 8 Regional Reference CF Care Centres located in 3 geographic Italian areas.To investigate a possible environmental acquisition of P. aeruginosa, the genetic relationship between strains from FC, from natural environment, household and nosocomial sources. The molecular epidemiological survey was assessed using DNAfingerprinting methods (Box-PCR e Multi Locus Sequence Typing)

Incidence of filamentosus fungi in sputum of patients affected by cystic fibrosis

Introduction. Cystic fibrosis (CF) is an autosomal recessive genetic disorder caused by a mutation of the gene encoding the CF protein CFTR. Patients with CF are frequently affected by respiratory infections due to specific pathogens.The role of filamentous fungi is well established in the case of allergic bronchopulmonary aspergillosis and invasive pulmonary infections in lung transplant patients, but their involvement in lung diseases outside of these cases remain to be clarified.The aim of our study was to monitor the impact of filamentous fungi in patients with CF. Methods. In the years 2007 and 2008 and during the first half of 2009 a total of 1046 samples of sputum collected from CF patients were analyzed. Of these 236 cases were positive for fungi. Results. Filamentous fungi were isolated from 44 patients, including 29 females and 15 males.The fungi were identified as Aspergillus fumigatus (70.04% of the cases), A. terreus (2.4%),A.flavus (11.4% ), Scedosporium apiospermum (3.8%), Penicillium spp (0.84%), Aspergillus spp. (1.26%) and Exophiala dermatitidis (0.24%). Conclusions. Based on the isolates, out of 44 cases the duration in time of colonization by filamentous fungi was constant with the same species in 11 patients, intermittent with the same or occasionally another species in 14 patients and present for no more than one semester in the remaining 19 cases

Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study

Abstract Background Routine culture-based diagnosis of Pseudomonas aeruginosa lung infection in Cystic Fibrosis (CF) patients can be hampered by the phenotypic variability of the microorganism, including its transition to a Viable But Non-Culturable (VBNC) state. The aim of this study was to validate an ecfX-targeting qPCR protocol developed to detect all viable P. aeruginosa bacteria and to identify VBNC forms in CF sputum samples. Methods The study involved 115 P. aeruginosa strains of different origins and 10 non-P. aeruginosa strains and 88 CF sputum samples, 41 Culture-Positive (CP) and 47 Culture-Negative (CN). Spiking assays were performed using scalar dilutions of a mixture of live and dead P. aeruginosa ATCC 9027 and a pooled P. aeruginosa-free sputum batch. Total DNA from sputum samples was extracted by a commercial kit, whereas a crude extract was obtained from the broth cultures. Extracellular DNA (eDNA) interference was evaluated by comparing the qPCR counts obtained from DNase-treated and untreated aliquots of the same samples. The statistical significance of the results was assessed by the Wilcoxon test and Student’s t test. Results The newly-developed qPCR protocol identified 96.6% of the P. aeruginosa isolates; no amplification was obtained with strains belonging to different species. Spiking assays supported protocol reliability, since counts always matched the amount of live bacteria, thus excluding the interference of dead cells and eDNA. The protocol sensitivity threshold was 70 cells/ml of the original sample. Moreover, qPCR detected P. aeruginosa in 9/47 CN samples and showed higher bacterial counts compared with the culture method in 10/41 CP samples. Conclusions Our findings demonstrate the reliability of the newly-developed qPCR protocol and further highlight the need for harnessing a non-culture approach to achieve an accurate microbiological diagnosis of P. aeruginosa CF lung infection and a greater understanding of its evolution

Intra-individual biological variation in sweat chloride concentrations in CF, CFTR dysfunction, and healthy pediatric subjects

BACKGROUND: The sweat test is one of the main diagnostic tools used in newborn screening programs and as a confirmatory test, in case of suspect of Cystic Fibrosis (CF). Since sweat chloride (Cl) concentration is also considered an appropriate parameter to explore the efficacy of CFTR modulators in clinical trials, it is crucial to evaluate the biological variability of this test in healthy and pathological conditions. The aim of this pilot study was to determine the intra-individual biological variability of sweat Cl, both in healthy individuals and CF patients and to assess its correlation with diet, season, and menstrual cycle. METHODS: Thirty-five out of 36 selected subjects (6-18 years) were enrolled by 2 CF care centers and assigned to 3 cohorts: CF, CFTR-related disorder (CFTR-RD) and healthy volunteers. Each participant was subjected to eight sweat tests in different conditions and time of the year. Data were analyzed using linear mixed effects models for repeated measures, taking also into account intra-individual correlations. RESULTS: We observed a high intra-individual variability of sweat Cl, with the lowest mean CV% values among CF patients (20.21 in CF, 29.74 in CFTR-RD, and 31.15 in healthy subjects). Gender and diet had no influence on sweat Cl variability, nor had pubertal age and menstrual phase. CONCLUSION: Results of this pilot study confirmed that sweat Cl variability is high in CF patients, although non-CF individuals displayed even higher mean CV% values. Season significantly influenced sweat test values only in CF patients, likely due to changes in their hydration status

Italian national survey on molecular epidemiology of Pseudomonas aeruginosa from pulmonary infection of Cystic Fibrosis patients

Pulmonary infection sustained by Pseudomonas aeruginosa is the leading cause of morbidity and mortality of patients affected by Cystic Fibrosis (FC), the most common inherited disease among Caucasian. P. aeruginosa is a ubiquitous microorganism, widely diffuse in the natural and nosocomial environment; however the initial source of acquisition and the way of transmission of this pathogen among CF patients are not yet elucidated. The acquisition of P. aeruginosa by the environment and/or patients to patients transmission was speculated. Moreover in some countries (Australia, United Kingdom) some highly virulent and transmissible strains, called epidemic strains, have spread within the CF care Centres. Aim of the present study was to determine the presence of possible diffuse lineages and the cross-infection degree of P. aeruginosa among Italian CF patients. For this purpose we carried out a national survey, determining the genetic relationship, by molecular typing of a collection of 530 strains recovered from respiratory specimens of 335 patients colonised in follow-up at 8 Regional Reference CF Care Centres located in 3 geographic Italian areas.To investigate a possible environmental acquisition of P. aeruginosa, the genetic relationship between strains from FC, from natural environment, household and nosocomial sources. The molecular epidemiological survey was assessed using DNAfingerprinting methods (Box-PCR e Multi Locus Sequence Typing)

The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Does Active Participation Improve the Quality?

(1) Background: Diagnostic testing for cystic fibrosis (CF) is based on a sweat chloride test (SCT) considering the appropriate signs and symptoms of the disease and results of a gene mutation analysis. In 2014, the Istituto Superiore di Sanità (ISS) established a pilot Italian external quality assessment program for CF SCT (Italian EQA-SCT), which is now a third party service carried out by the ISS. (2) Methods: The ongoing scheme is prospective, enrollment is voluntary, and the payment of a fee is required. Results are shared through a dedicated web-facility. Assessment covers the analysis, interpretation, and reporting of results. (3) Results: Thirteen, fifteen, sixteen, and fifteen different laboratories, respectively, participated from 2015 to 2016 and from 2018 to 2019 in the Italian EQA-SCT scheme. Eleven different laboratories participated each year in all four rounds of the Italian EQA-SCT. (4) Conclusions: The overall results obtained from the laboratories participating constantly clearly show that their qualitative and quantitative performance improved significantly. This is due to the opportunity—after receiving the EQA results—to constantly review their performance and address any inconsistencies. We firmly believe that participation in the EQA program will improve the quality of participating laboratories and that EQA participation should become mandatory as a fundamental requirement for laboratory accreditation